Name Development Level Target Family
Name Description
bevacizumab An anti-VEGF recombinant monoclonal antibody consisting of humanized murine antibody. It inhibits VEGF receptors and prevents the proliferation of blood vessels.
TCRDv4.6.9
DrugCentral Indication
DrugCentral
bevacizumab